These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26306030)

  • 41. Inhibitors of serine proteases as potential therapeutic agents: the road from thrombin to tryptase to cathepsin G.
    Maryanoff BE
    J Med Chem; 2004 Feb; 47(4):769-87. PubMed ID: 14761180
    [No Abstract]   [Full Text] [Related]  

  • 42. Dipeptide proline diphenyl phosphonates are potent, irreversible inhibitors of seprase (FAPalpha).
    Gilmore BF; Lynas JF; Scott CJ; McGoohan C; Martin L; Walker B
    Biochem Biophys Res Commun; 2006 Jul; 346(2):436-46. PubMed ID: 16769036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metal mediated protease inhibition: design and synthesis of inhibitors of the human cytomegalovirus (hCMV) protease.
    Dhanak D; Burton G; Christmann LT; Darcy MG; Elrod KC; Kaura A; Keenan RM; Link JO; Peishoff CE; Shah DH
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2279-82. PubMed ID: 11055338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative study of the active site caging of serine proteases: thrombin and factor Xa.
    Thuring JW; Li H; Porter NA
    Biochemistry; 2002 Feb; 41(6):2002-13. PubMed ID: 11827547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of trypsin and thrombin by amino(4-amidinophenyl)methanephosphonate diphenyl ester derivatives: X-ray structures and molecular models.
    Bertrand JA; Oleksyszyn J; Kam CM; Boduszek B; Presnell S; Plaskon RR; Suddath FL; Powers JC; Williams LD
    Biochemistry; 1996 Mar; 35(10):3147-55. PubMed ID: 8605148
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.
    Nardini M; Pesce A; Rizzi M; Casale E; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M
    J Mol Biol; 1996 May; 258(5):851-9. PubMed ID: 8637015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluorescent derivatives of diphenyl [1-(N-peptidylamino)alkyl]phosphonate esters: synthesis and use in the inhibition and cellular localization of serine proteases.
    Abuelyaman AS; Hudig D; Woodard SL; Powers JC
    Bioconjug Chem; 1994; 5(5):400-5. PubMed ID: 7849068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protease inhibitors: synthesis and QSAR study of novel classes of nonbasic thrombin inhibitors incorporating sulfonylguanidine and O-methylsulfonylisourea moieties at P1.
    Supuran CT; Scozzafava A; Briganti F; Clare BW
    J Med Chem; 2000 May; 43(9):1793-806. PubMed ID: 10794696
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biotinylated isocoumarins, new inhibitors and reagents for detection, localization, and isolation of serine proteases.
    Kam CM; Abuelyaman AS; Li Z; Hudig D; Powers JC
    Bioconjug Chem; 1993; 4(6):560-7. PubMed ID: 8305526
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design and synthesis of novel and potent inhibitors of the type II transmembrane serine protease, matriptase, based upon the sunflower trypsin inhibitor-1.
    Li P; Jiang S; Lee SL; Lin CY; Johnson MD; Dickson RB; Michejda CJ; Roller PP
    J Med Chem; 2007 Nov; 50(24):5976-83. PubMed ID: 17985858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. α-Ketobenzothiazole Serine Protease Inhibitors of Aberrant HGF/c-MET and MSP/RON Kinase Pathway Signaling in Cancer.
    Han Z; Harris PK; Karmakar P; Kim T; Owusu BY; Wildman SA; Klampfer L; Janetka JW
    ChemMedChem; 2016 Mar; 11(6):585-99. PubMed ID: 26889658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Site-selective chemical modification of chymotrypsin using peptidyl derivatives bearing optically active diphenyl 1-amino-2-phenylethylphosphonate: Stereochemical effect of the diphenyl phosphonate moiety.
    Ono S; Nakai T; Kuroda H; Miyatake R; Horino Y; Abe H; Umezaki M; Oyama H
    Biopolymers; 2016 Nov; 106(4):521-30. PubMed ID: 26615968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro blood compatibility of polymeric biomaterials through covalent immobilization of an amidine derivative.
    Gouzy MF; Sperling C; Salchert K; Pompe T; Streller U; Uhlmann P; Rauwolf C; Simon F; Böhme F; Voit B; Werner C
    Biomaterials; 2004 Aug; 25(17):3493-501. PubMed ID: 15020123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombin inhibition by novel benzamidine derivatives: a free-energy perturbation study.
    Guimarães CR; Bicca de Alencastro R
    J Med Chem; 2002 Nov; 45(23):4995-5004. PubMed ID: 12408710
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of non-competitive thrombin inhibitor derived from competitive tryptase inhibitor skeleton: Shift in molecular recognition resulted from skeletal conversion of carboxylate into phosphonate.
    Aoyama H; Ijuin R; Kato JY; Urushiyama S; Tetsuhashi M; Hashimoto Y; Yokomatsu T
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3676-80. PubMed ID: 26122211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel amidine-containing peptidyl phosphonates as irreversible inhibitors for blood coagulation and related serine proteases.
    Oleksyszyn J; Boduszek B; Kam CM; Powers JC
    J Med Chem; 1994 Jan; 37(2):226-31. PubMed ID: 8295209
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Understanding binding selectivity toward trypsin and factor Xa: the role of aromatic interactions.
    Di Fenza A; Heine A; Koert U; Klebe G
    ChemMedChem; 2007 Mar; 2(3):297-308. PubMed ID: 17191291
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative molecular modeling analysis of-5-amidinoindole and benzamidine binding to thrombin and trypsin: specific H-bond formation contributes to high 5-amidinoindole potency and selectivity for thrombin and factor Xa.
    Zhou Y; Johnson ME
    J Mol Recognit; 1999; 12(4):235-41. PubMed ID: 10440994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nonbenzamidine acylsulfonamide tissue factor-factor VIIa inhibitors.
    Glunz PW; Zhang X; Zou Y; Delucca I; Nirschl AH; Cheng X; Weigelt CA; Cheney DL; Wei A; Anumula R; Luettgen JM; Rendina AR; Harpel M; Luo G; Knabb R; Wong PC; Wexler RR; Priestley ES
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5244-8. PubMed ID: 23845220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.